Type:

Other

Description:

DNAi location: Applications>Genes and Medicine>gene hunting>Mark Skolnick Mark Skolnick is Chief Scientific Officer at Myriad Genetics, Inc. Mark Skolnick is a geneticist who was involved in early genetic linkage studies involving Mormons. In 1990, he formed a company called Myriad Genetics to use the power of the Mormon family history and pedigrees to help map and clone genes. Myriad's first target was a breast cancer gene (BRCA1). In 1994, a group from Myriad and their collaborators announced that they located a strong candidate for BRCA1. Their patent on this gene was granted in 1997. Although they were not the first to find the second breast cancer gene (BRCA2), Myriad was the first to isolate it. They patented BRCA2 in 2001.

Subjects:

    Education Levels:

      Keywords:

      NSDL,clone genes,population genetics,myriad genetics inc,mormons,utah population,image description,biological elements,oai:nsdl.org:2200/20081106034250181T,hunting,patent,Social Sciences,medicine,breast cancer,pedigrees,brca1,NSDL_SetSpec_BEN,geneticist,Life Science,Chemistry,collaborators,target,genetic linkage studies,breast cancer gene,mormon family history,location applications

      Language:

      English

      Access Privileges:

      Public - Available to anyone

      License Deed:

      Creative Commons Attribution Non-Commercial Share Alike

      Collections:

      None
      This resource has not yet been aligned.
      Curriki Rating
      'NR' - This resource has not been rated
      NR
      'NR' - This resource has not been rated

      This resource has not yet been reviewed.

      Not Rated Yet.

      Non-profit Tax ID # 203478467